IDH2 and astrocytoma (excluding glioblastoma): While inactivation of TP53 is typical for the complete spectrum of IDH-mutant astrocytomas, alterations of the retinoblastoma tumor-suppressor gene (RB1) or related pathway components have been implicated in the malignant progression of IDH-mutant astrocytomas.